ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year... (9000) 74000 Deferred reven...)

HOME >> BIOLOGY >> TECHNOLOGY

ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year

Date:2/6/2008

9,000) 74,000

Deferred revenue (332,000) (373,000)

Other current liabilities 304,000 109,000

Net cash used in operating activities (3,485,000) (3,621,000)

Cash flows from investing activities:

Capital expenditures (225,000) (165,000)

Purchase of investments (23,482,000) (25,533,000)

Maturities of investments 25,000,000 36,000,000

Net cash provided by investing

activities: 1,293,000 10,302,000

Cash flows from financing activities:

Payments on capital lease obligations (8,000) (11,000)

Exercise of stock options and warrants 266,000 1,028,000

Net cash provided by financing activities 258,000 1,017,000

Net (decrease)/increase in cash and cash

equivalents (1,934,000) 7,698,000

Cash and cash equivalents at beginning of

period 5,730,000 3,527,000

Cash and cash equivalents at end of period $3,796,000 $11,225,000

This press release, including statements regarding financial information for future periods, contain forward-looking statements, and such statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
2. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
3. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
5. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
8. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
9. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
10. Helix BioPharma Corp. announces fiscal 2007 results
11. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington

Post Your Comments:

ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year...(9000) 74000 Deferred reven...)